Vitenskapelige artikler
Bergman Andries M, Adema Auke D, Balzarini Jan, Bruheim Skjalg, Fichtner Iduna, Noordhuis Paul, Fodstad Oystein, Myhren Finn, Sandvold Marit L, Hendriks Hans R, Peters Godefridus J
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Invest New Drugs 2010 Jan. Epub 2010 jan 12
- PMID:
- 20066470
Brekke Helge R, Kolberg Matthias, Skotheim Rolf I, Hall Kirsten S, Bjerkehagen Bodil, Risberg Björn, Domanski Henryk A, Mandahl Nils, Liestøl Knut, Smeland Sigbjørn, Danielsen Håvard E, Mertens Fredrik, Lothe Ragnhild A
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.
Neuro Oncol 2009 Oct;11(5):514-28. Epub 2009 jan 30
- PMID:
- 19182148
Gebre-Medhin S, Broberg K, Jonson T, Gorunova L, von Steyern F Vult, Brosjö O, Jin Y, Gisselsson D, Panagopoulos I, Mandahl N, Mertens F
Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone.
Cytogenet Genome Res 2009;124(2):121-7. Epub 2009 mai 5
- PMID:
- 19420923
Kresse Stine H, Ohnstad Hege O, Paulsen Erik B, Bjerkehagen Bodil, Szuhai Karoly, Serra Massimo, Schaefer Karl-Ludwig, Myklebost Ola, Meza-Zepeda Leonardo A
LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Genes Chromosomes Cancer 2009 Aug;48(8):679-93.
- PMID:
- 19441093
Ottaviano Laura, Schaefer Karl-Ludwig, Gajewski Melanie, Huckenbeck Wolfgang, Baldus Stefan, Rogel Uwe, Mackintosh Carlos, de Alava Enrique, Myklebost Ola, Kresse Stine H, Meza-Zepeda Leonardo A, Serra Massimo, Cleton-Jansen Anne-Marie, Hogendoorn Pancras C W, Buerger Horst, Aigner Thomas, Gabbert Helmut E, Poremba Christopher
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.
Genes Chromosomes Cancer 2010 Jan;49(1):40-51.
- PMID:
- 19787792
Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina G I, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.
Oncogene 2009 Nov;28(46):4065-74. Epub 2009 sep 7
- PMID:
- 19734943
Bjerkehagen Wejde Hanssson Domanski Bøhling
SSG Pathology review experiences and histological grading of malignancy in sarcomas
Acta Ort supplementum No 334 Vol 80, 2009 p 31-36
Boye K, Mælandsmo GM.
S100A4 and Metastasis: A Small Actor Playing Many Roles
Am J Pathol 2009. Epub ahead of print.
Brekke HR, Ribeiro FR, Kolberg M, Ågesen T, Eken M, Lind GE, Eknæs M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI., Lothe RA
Genomic loss from chromosome 10 and X in malignant peripheral nerve sheath tumors predict poor disease outcome
J Clin Oncol in press
Bruland ØS, Høifødt H, Hall KS, Smeland S, Fodstad Ø
Bone Marrow Micrometastases Studied by an Immunomagnetic Isolation Procedure in Extremity Localized Non-metastatic Osteosarcoma
In: Jaffe, Norman; Bruland, Øyvind S.; Bielack, Stefan (Eds.) Pediatric and Adolescent Osteosarcoma. Series: Cancer Treatment and Research, Vol. 152 , ISBN: 978-1-4419-0283-
Bruland ØS, Bauer H, Alvegaard T, Smeland S
Treatment of Osteosarcoma. The Scandinavian Sarcoma Group Experience.
In: Jaffe, Norman; Bruland, Øyvind S.; Bielack, Stefan (Eds.) Pediatric and Adolescent Osteosarcoma. Series: Cancer Treatment and Research , Vol. 152 , ISBN: 978-1-4419-0283-2
Grotterød I, Mælandsmo G. M, Boye K
Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kB.
. BMC Cancer, Submitted
Hall KS, Eriksson M, Bruland Ø, Engellau J, Trovik CS
Treatment of soft tissue sarcoma of the extremity and trunk wall
Acta Ortopaedica (suppl 334), 80; 52-59, 2009.
Jaffe, Norman; Bruland, Øyvind S.; Bielack, Stefan (Eds
Pediatric and Adolescent Osteosarcoma.
Series: Cancer Treatment and Research 2009, Vol. 152 , 2009
Kildal W, Abeler VM, Kristensen GB, Jenstad M, Thoresen SO, Danielsen HE.
The prognostic value of DNA ploidy in a total population of uterine sarcomas
Annals of Oncology 2009; 20:1037–41
König M, Mork J, Hall KS, Osnes T
. Multimodal treatment of osteogenic sarcoma of the jaw.
Skull base 2009 "epub ahead of printing
Schwarz R, Carrle D, Kevric M, Bruland O, Bielack S, COSS
. Results of radiotherapy in osteosarcoma.
. Strahlenther. Onkol 2009; 185 Suppl 1, 6
Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S.
The Role of Radiotherapy in Oseosarcoma
In: Jaffe, Norman; Bruland, Øyvind S.; Bielack, Stefan (Eds.) Pediatric and Adolescent Osteosarcoma. Series: Cancer Treatment and Research. Vol. 152 , ISBN: 978-1-4419-0283-2
Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Bjork O, Alvegaard TA
Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol.
. Acta Orthop 2009; 80 Suppl 334, 60-66
Smeland S, Wiebe T, Monge OR, Brosjø O, Bøhling T, Hjorth L, Hall KS, Jakobson Å, Alvegård TA
. Treatment of localized Ewing sarcoma family of tumors
Acta Ortopaedica (suppl 334), 80; 75-78, 2009.
Forskningsprosjekter
Forskningsprosjekt: Studies of cellular mechanisms in cancer progression and metastasis influence of S100A4
Gisle Berge, Oslo universitetssykehus HF
- Prosjektperiode:
- 2009 - 2011
- Deltakende helseregion:
- HSØ
Forskningsprosjekt: Ekspresjon av det metastasefremmende proteinet S 100A4 i bløtvevssarkomer
Kjetil Boye, Oslo universitetssykehus HF
- Prosjektperiode:
- 2009 - 2011
- Deltakende helseregion:
- HSØ
Doktorgradsprosjekt: Functional studies of gene products involved in cancer metastasis -possibility for therapeutic intervention
Gunhild Mælandsmo, Oslo universitetssykehus HF
- Prosjektperiode:
- 2008 - 2012
- Deltakende helseregion:
- HSØ
Doktorgradsprosjekt: Biologisk tilpasset tterapi mot ben- og bindevevskreft
Ola Myklebost, Oslo universitetssykehus HF
- Prosjektperiode:
- 2007 - 2012
- Deltakende helseregion:
- HSØ
Forskningsprosjekt: Strålebehandlingh av bløtvevssarkomer: Planlegging og evaluering med PET og MRI
Arne Skretting, Oslo universitetssykehus HF
- Prosjektperiode:
- 2008 - 2011
- Deltakende helseregion:
- HSØ
Doktorgradsprosjekt: Christoph Muller: Prognostiske markører ved Oslosarkom
Ola Myklebost, Oslo universitetssykehus HF
- Prosjektperiode:
- 2007 - 2010
- Deltakende helseregion:
- HSØ
Doktorgradsprosjekt: GIST
Øyvind Bruland, Oslo universitetssykehus HF
- Prosjektperiode:
- 2009 - 2013
- Deltakende helseregion:
- HSØ
Doktorgradsprosjekt: Strålebehandling av sarkomer
Øyvind Bruland, Oslo universitetssykehus HF
- Prosjektperiode:
- 2008 - 2012
- Deltakende helseregion:
- HV HSØ
Doktorgradsprosjekt: Behandling av metastaser i columna i Sør-ØstNorge
Olga Zaikova, Oslo universitetssykehus HF
- Prosjektperiode:
- 2007 - 2010
- Deltakende helseregion:
- HSØ
